PTC Therapeutics Inc
DUS:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
|
Nick Scali Ltd
F:NJN
|
AU |
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
L
|
Lagardere SA
SWB:LAG
|
FR |
|
Standard Bank Group Ltd
F:SKCS
|
ZA |
|
I
|
Intesa Sanpaolo SpA
BMV:ISPN
|
IT |
|
Recruit Holdings Co Ltd
F:1RH
|
JP |
|
Sparebanken Vest
OSE:SVEG
|
NO |
|
J
|
Jabil Inc
XMUN:JBL
|
US |
|
H
|
Honeywell International Inc
F:ALD
|
US |
|
Imperial Hotel Ltd
TSE:9708
|
JP |
|
Tenaris SA
BMV:TS
|
LU |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
W
|
Walmart Inc
XMUN:WMT
|
US |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
BH3 is 86.56 EUR with a low forecast of 60.98 EUR and a high forecast of 117.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
86.56
EUR
According to Wall Street analysts, the average 1-year price target for
BH3 is 86.56 EUR with a low forecast of 60.98 EUR and a high forecast of 117.73 EUR.